Sequence Information

    • DRAMP ID

    • DRAMP29325

    • Name

    • TD-1792(Cefilavancin)

    • Sequence

    • Not available

    • Description

    • Cefilavancin is a covalently-linked glycopeptide-cephalosporin (beta-lactam) heterodimer antibiotic that exhibits substantially greater activity than its component parts against Gram-positive bacteria.

    • Activity

    • Antibacterial

    • Target Organism

      • No MICs found on DRAMP database

    • Reference

      • Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.(PMID: 29353377)

Clinical Information

    • Medical use

    • Gram-positive infections, Skin and soft tissue infections

    • Company

    • GlaxoSmithKline Co., Theravance Biopharma Inc., R-Pharm

    • Stage of Development

    • Phase III

    • Comments

    • No more comments

    • Clinical Trials

    • NCT00442832